Immutep Ltd Files Form 6-K
Ticker: PRRUF · Form: 6-K · Filed: Apr 30, 2024 · CIK: 1506184
| Field | Detail |
|---|---|
| Company | Immutep Ltd (PRRUF) |
| Form Type | 6-K |
| Filed Date | Apr 30, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, foreign-private-issuer
TL;DR
Immutep Ltd (formerly Prima BioMed) filed a 6-K, just standard corporate info update.
AI Summary
Immutep Limited filed a Form 6-K on April 29, 2024, reporting its status as a foreign private issuer. The company, formerly known as Prima BioMed Ltd, is incorporated in Australia and its fiscal year ends on June 30. Its principal executive offices are located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
Why It Matters
This filing provides routine corporate information for Immutep Ltd, a biopharmaceutical company, which is important for investors tracking its regulatory compliance and basic corporate details.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not contain new financial or operational information that would typically increase risk.
Key Players & Entities
- Immutep Limited (company) — Registrant
- Prima BioMed Ltd (company) — Former company name
- April 29, 2024 (date) — Filing date
- Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia (location) — Principal executive office address
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information as a foreign private issuer, as required by the U.S. Securities and Exchange Commission.
What was Immutep Limited's former name?
Immutep Limited was formerly known as Prima BioMed Ltd.
Where are Immutep Limited's principal executive offices located?
Immutep Limited's principal executive offices are located at Level 32, Australia Square, 264 George Street, Sydney NSW 2000, Australia.
What is the fiscal year end for Immutep Limited?
Immutep Limited's fiscal year ends on June 30.
Does Immutep Limited file annual reports under Form 20-F or Form 40-F?
Immutep Limited files annual reports under cover of Form 20-F.
Filing Stats: 255 words · 1 min read · ~1 pages · Grade level 16.9 · Accepted 2024-04-30 06:05:50
Filing Documents
- d793828d6k.htm (6-K) — 9KB
- d793828dex991.htm (EX-99.1) — 102KB
- g793828dsp04aa.jpg (GRAPHIC) — 9KB
- 0001193125-24-123571.txt ( ) — 126KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: April 29, 2024 IMMUTEP LIMITED By: /s/ Marc Voigt Name: Marc Voigt Title: Chief Executive Officer